ADCT - Adc Therapeutics SA
Close
2.9
0.030 1.034%
Share volume: 289,784
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.87
0.03
1.05%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-5.54%
1 Month
-16.43%
3 Months
-15.70%
6 Months
-40.33%
1 Year
141.67%
2 Year
-57.04%
Key data
Stock price
$2.90
DAY RANGE
$2.82 - $2.98
52 WEEK RANGE
$0.36 - $6.04
52 WEEK CHANGE
$1.38
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO:
Region: US
Website: adctherapeutics.com
Employees: 310
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: adctherapeutics.com
Employees: 310
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
adc therapeutics is a biotechnology company located in lausanne, vaud, switzerland.
Recent news